PDGFRB and Alzheimer disease: Compared to the control group, the expression of PDGFRβ in the cerebral vasculature of AD mice with P2Y1-shRNA treatment was significantly increased, while that of WT mice was the highest among the three groups (Fig. 6, A and B).